BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7840188)

  • 1. Effect of acute glucagon removal on metabolic response to infection in conscious dog.
    McGuinness OP; Lacy DB; Anderson J
    Am J Physiol; 1995 Jan; 268(1 Pt 1):E92-9. PubMed ID: 7840188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglucagonemia and hepatic glucose metabolism during infection in the conscious dog.
    McGuinness OP; Lacy DB; Eliasson K
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E580-8. PubMed ID: 8928762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog.
    McGuinness OP; Murrell S; Moran C; Bracy D; Cherrington AD
    Metabolism; 1994 Oct; 43(10):1310-7. PubMed ID: 7934986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of basal glucagon in maintaining hepatic glucose production during a prolonged fast in conscious dogs.
    Hendrick GK; Wasserman DH; Frizzell RT; Williams PE; Lacy DB; Jaspan JB; Cherrington AD
    Am J Physiol; 1992 Sep; 263(3 Pt 1):E541-9. PubMed ID: 1415534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of hepatic glucose output by glucagon and insulin in the intact dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Lacy WW; Park CR
    Biochem Soc Symp; 1978; (43):31-45. PubMed ID: 373768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work.
    Wasserman DH; Spalding JA; Lacy DB; Colburn CA; Goldstein RE; Cherrington AD
    Am J Physiol; 1989 Jul; 257(1 Pt 1):E108-17. PubMed ID: 2665514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs.
    Shiota M; Jackson PA; Bischoff H; McCaleb M; Scott M; Monohan M; Neal DW; Cherrington AD
    Am J Physiol; 1997 Nov; 273(5):E868-79. PubMed ID: 9374671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs.
    Frizzell RT; Hendrick GK; Biggers DW; Lacy DB; Donahue DP; Green DR; Carr RK; Williams PE; Stevenson RW; Cherrington AD
    Diabetes; 1988 Jun; 37(6):749-59. PubMed ID: 3289995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glucose production by NEFA and gluconeogenic precursors during chronic glucagon infusion.
    McGuinness OP; Ejiofor J; Audoly LP; Schrom N
    Am J Physiol; 1998 Sep; 275(3):E432-9. PubMed ID: 9725809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Net hepatic gluconeogenic amino acid uptake in response to peripheral versus portal amino acid infusion in conscious dogs.
    Moore MC; Hsieh PS; Flakoll PJ; Neal DW; Cherrington AD
    J Nutr; 1999 Dec; 129(12):2218-24. PubMed ID: 10573553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
    Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
    Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of infection on hepatic disposal of a peripheral glucose infusion in the conscious dog.
    McGuinness OP; Jacobs J; Moran C; Lacy B
    Am J Physiol; 1995 Aug; 269(2 Pt 1):E199-207. PubMed ID: 7653536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs.
    Dobbins RL; Connolly CC; Neal DW; Palladino LJ; Parlow AF; Cherrington AD
    Am J Physiol; 1991 Dec; 261(6 Pt 1):E773-81. PubMed ID: 1767838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in hepatic gluconeogenic amino acid uptake and gluconeogenesis in the endotoxin treated conscious dog.
    Meinz H; Lacy DB; Ejiofor J; McGuinness OP
    Shock; 1998 Apr; 9(4):296-303. PubMed ID: 9565259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
    Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intraportal N(omega)-nitro-L-arginine infusion on hepatic glucose metabolism in total parenteral nutrition-adapted dogs: interaction with infection.
    Chen SS; Donmoyer CM; Ejiofor J; McCay J; Archuletta R; Lacy DB; McGuinness OP
    Metabolism; 2002 Mar; 51(3):274-83. PubMed ID: 11887160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog.
    Stevenson RW; Williams PE; Cherrington AD
    Diabetologia; 1987 Oct; 30(10):782-90. PubMed ID: 3322904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acute elevations in plasma cortisol levels on alanine metabolism in the conscious dog.
    Goldstein RE; Reed GW; Wasserman DH; Williams PE; Lacy DB; Buckspan R; Abumrad NN; Cherrington AD
    Metabolism; 1992 Dec; 41(12):1295-303. PubMed ID: 1461135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic denervation does not significantly change the response of the liver to glucagon in conscious dogs.
    Wada M; Connolly CC; Tarumi C; Neal DW; Cherrington AD
    Am J Physiol; 1995 Feb; 268(2 Pt 1):E194-203. PubMed ID: 7864094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.